Molecular Templates, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Net Loss Per Common Share (Tables)

Net Loss Per Common Share (Tables)

12 Months Ended

Dec. 31, 2013

Reconciliation of Numerator and Denominator

A reconciliation of the numerator and denominator used in the calculation is as follows (in thousands, except per share amounts):


	Years Ended December 31,
	2013			2012			2011
Numerator:
Net loss	$	(28,415	)	$	(71,135	)	$	(25,653	)

Denominator:
Weighted-average number of common shares outstanding		57,832			54,219			45,900

Net loss per share:
Basic	$	(0.49	)	$	(1.31	)	$	(0.56	)

Diluted	$	(0.49	)	$	(1.31	)	$	(0.56	)

Warrants, Options and Purchase Rights Excluded from Computation of Diluted Net Loss Per Common Share

The following warrants, outstanding options and purchase rights under the Company’s ESPP were excluded from the computation of diluted net loss per common share for the periods presented because including them would have had an antidilutive effect (in thousands):


	December 31,
	2013		2012		2011
Shares issuable upon exercise of warrants		8,282		11,583		16,643
Shares issuable upon exercise of stock options		6,527		5,099		3,672
Shares issuable related to the ESPP		64		79		70